Status and phase
Conditions
Treatments
About
This clinical trial is a multi-center, double-blind, randomized, active controlled , parallel design, non-inferiority phase 4 study to evaluate the efficacy and safety of Entelon 150mg in 278 patients with chronic venous disease.
Full description
This study is to prove that Entelon tab. 150mg is non-inferior in clinical efficacy and safety compared to Venitol tab. for 8 weeks in patients suffering from chronic venous disease.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
19 years ≤ age ≤ 80 years
Those who are diagnosed as CEAP Classification Class 1 ~ Class 3
Those who have the Venous Duplex ultrasonography result at least one of the following
Those who have completed the washout period as following until the baseline, including the screening period
Those who provide written consent voluntarily to participate in this clinical trial
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
278 participants in 2 patient groups
Loading...
Central trial contact
Nahyun Kang
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal